Visceral adiposity indicators and cardiovascular risk in hemodialytic patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Arquivos de Endocrinologia e Metabolismo (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600811 |
Resumo: | ABSTRACT Objective: Cardiovascular diseases represent the main cause of death in chronic kidney disease (CKD). We aimed to evaluate the prevalence and association of the hypertriglyceridemia-waist phenotype (HWP) and visceral adiposity index (VAI) with cardiometabolic risk factors (CR) in patients with CKD on hemodialysis (HD). Materials and methods: The study is based on a cross-sectional design with 265 HD patients in two cities in northeastern Brazil. The VAI was calculated considering the variables body mass index (BMI), waist circumference (WC), triglycerides (TG) and high density lipoprotein cholesterol (HDL-c). HWP was defined as the concomitant elevation of WC and TG. The Poisson Regression Model with robust variance estimation was adjusted considering a hierarchical approach for explanatory variables. Prevalence ratios (PR) were also estimated. The level of significance adopted was 5%. Results: In our study HWP and VAI prevalence’s were 29.82% and 58.49%, respectively. In the final model, there was an association between VAI and female gender (PR = 1.46; p < 0.0001) and high body fat (% BF) (PR = 1.33; p < 0.0019). HWP was associated with females (PR = 1.80; p = 0.002), alcohol consumption (PR = 1.58; p = 0.033), obesity (PR = 1.89; p = 0.0001), high %BF (PR = 1.76; p = 0.012) and reduced HDL-c (PR = 1.48; p = 0.035). Conclusion: The HWP stood out as the association with more CR factors, representing a promising method for tracking cardiometabolic risk in HD patients, mainly female. |
id |
SBEM-1_87938eb8f189338c82a1eeb142a7fda7 |
---|---|
oai_identifier_str |
oai:scielo:S2359-39972021000600811 |
network_acronym_str |
SBEM-1 |
network_name_str |
Arquivos de Endocrinologia e Metabolismo (Online) |
repository_id_str |
|
spelling |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patientsChronic renal insufficiencycardiovascular diseasesadiposityABSTRACT Objective: Cardiovascular diseases represent the main cause of death in chronic kidney disease (CKD). We aimed to evaluate the prevalence and association of the hypertriglyceridemia-waist phenotype (HWP) and visceral adiposity index (VAI) with cardiometabolic risk factors (CR) in patients with CKD on hemodialysis (HD). Materials and methods: The study is based on a cross-sectional design with 265 HD patients in two cities in northeastern Brazil. The VAI was calculated considering the variables body mass index (BMI), waist circumference (WC), triglycerides (TG) and high density lipoprotein cholesterol (HDL-c). HWP was defined as the concomitant elevation of WC and TG. The Poisson Regression Model with robust variance estimation was adjusted considering a hierarchical approach for explanatory variables. Prevalence ratios (PR) were also estimated. The level of significance adopted was 5%. Results: In our study HWP and VAI prevalence’s were 29.82% and 58.49%, respectively. In the final model, there was an association between VAI and female gender (PR = 1.46; p < 0.0001) and high body fat (% BF) (PR = 1.33; p < 0.0019). HWP was associated with females (PR = 1.80; p = 0.002), alcohol consumption (PR = 1.58; p = 0.033), obesity (PR = 1.89; p = 0.0001), high %BF (PR = 1.76; p = 0.012) and reduced HDL-c (PR = 1.48; p = 0.035). Conclusion: The HWP stood out as the association with more CR factors, representing a promising method for tracking cardiometabolic risk in HD patients, mainly female.Sociedade Brasileira de Endocrinologia e Metabologia2021-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600811Archives of Endocrinology and Metabolism v.65 n.6 2021reponame:Arquivos de Endocrinologia e Metabolismo (Online)instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)instacron:SBEM10.20945/2359-3997000000421info:eu-repo/semantics/openAccessMelo,Dejane de AlmeidaSantos,Alcione Miranda dosFurtado,Elane Viana HortegalFrança,Ana Karina TeixeiraSantos,Elisângela Milhomem dosArruda,Ilma Kruze Grande deCarvalho,Tuane Rodrigues dePinho,Claudia Porto SabinoDiniz,Alcides da SilvaLemos,Maria da Conceição Chaves deeng2021-12-03T00:00:00Zoai:scielo:S2359-39972021000600811Revistahttps://www.aem-sbem.com/https://old.scielo.br/oai/scielo-oai.php||aem.editorial.office@endocrino.org.br2359-42922359-3997opendoar:2021-12-03T00:00Arquivos de Endocrinologia e Metabolismo (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)false |
dc.title.none.fl_str_mv |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients |
title |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients |
spellingShingle |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients Melo,Dejane de Almeida Chronic renal insufficiency cardiovascular diseases adiposity |
title_short |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients |
title_full |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients |
title_fullStr |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients |
title_full_unstemmed |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients |
title_sort |
Visceral adiposity indicators and cardiovascular risk in hemodialytic patients |
author |
Melo,Dejane de Almeida |
author_facet |
Melo,Dejane de Almeida Santos,Alcione Miranda dos Furtado,Elane Viana Hortegal França,Ana Karina Teixeira Santos,Elisângela Milhomem dos Arruda,Ilma Kruze Grande de Carvalho,Tuane Rodrigues de Pinho,Claudia Porto Sabino Diniz,Alcides da Silva Lemos,Maria da Conceição Chaves de |
author_role |
author |
author2 |
Santos,Alcione Miranda dos Furtado,Elane Viana Hortegal França,Ana Karina Teixeira Santos,Elisângela Milhomem dos Arruda,Ilma Kruze Grande de Carvalho,Tuane Rodrigues de Pinho,Claudia Porto Sabino Diniz,Alcides da Silva Lemos,Maria da Conceição Chaves de |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Melo,Dejane de Almeida Santos,Alcione Miranda dos Furtado,Elane Viana Hortegal França,Ana Karina Teixeira Santos,Elisângela Milhomem dos Arruda,Ilma Kruze Grande de Carvalho,Tuane Rodrigues de Pinho,Claudia Porto Sabino Diniz,Alcides da Silva Lemos,Maria da Conceição Chaves de |
dc.subject.por.fl_str_mv |
Chronic renal insufficiency cardiovascular diseases adiposity |
topic |
Chronic renal insufficiency cardiovascular diseases adiposity |
description |
ABSTRACT Objective: Cardiovascular diseases represent the main cause of death in chronic kidney disease (CKD). We aimed to evaluate the prevalence and association of the hypertriglyceridemia-waist phenotype (HWP) and visceral adiposity index (VAI) with cardiometabolic risk factors (CR) in patients with CKD on hemodialysis (HD). Materials and methods: The study is based on a cross-sectional design with 265 HD patients in two cities in northeastern Brazil. The VAI was calculated considering the variables body mass index (BMI), waist circumference (WC), triglycerides (TG) and high density lipoprotein cholesterol (HDL-c). HWP was defined as the concomitant elevation of WC and TG. The Poisson Regression Model with robust variance estimation was adjusted considering a hierarchical approach for explanatory variables. Prevalence ratios (PR) were also estimated. The level of significance adopted was 5%. Results: In our study HWP and VAI prevalence’s were 29.82% and 58.49%, respectively. In the final model, there was an association between VAI and female gender (PR = 1.46; p < 0.0001) and high body fat (% BF) (PR = 1.33; p < 0.0019). HWP was associated with females (PR = 1.80; p = 0.002), alcohol consumption (PR = 1.58; p = 0.033), obesity (PR = 1.89; p = 0.0001), high %BF (PR = 1.76; p = 0.012) and reduced HDL-c (PR = 1.48; p = 0.035). Conclusion: The HWP stood out as the association with more CR factors, representing a promising method for tracking cardiometabolic risk in HD patients, mainly female. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600811 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000600811 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.20945/2359-3997000000421 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Endocrinologia e Metabologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Endocrinologia e Metabologia |
dc.source.none.fl_str_mv |
Archives of Endocrinology and Metabolism v.65 n.6 2021 reponame:Arquivos de Endocrinologia e Metabolismo (Online) instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) instacron:SBEM |
instname_str |
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) |
instacron_str |
SBEM |
institution |
SBEM |
reponame_str |
Arquivos de Endocrinologia e Metabolismo (Online) |
collection |
Arquivos de Endocrinologia e Metabolismo (Online) |
repository.name.fl_str_mv |
Arquivos de Endocrinologia e Metabolismo (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) |
repository.mail.fl_str_mv |
||aem.editorial.office@endocrino.org.br |
_version_ |
1752122518417702912 |